Benitec Biopharma (BNTC) Receivables (2019 - 2025)
Historic Receivables for Benitec Biopharma (BNTC) over the last 7 years, with Q1 2025 value amounting to $3000.0.
- Benitec Biopharma's Receivables fell 9433.96% to $3000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $3000.0, marking a year-over-year decrease of 9433.96%. This contributed to the annual value of $229000.0 for FY2024, which is 31636.36% up from last year.
- As of Q1 2025, Benitec Biopharma's Receivables stood at $3000.0, which was down 9433.96% from $2000.0 recorded in Q4 2024.
- In the past 5 years, Benitec Biopharma's Receivables ranged from a high of $229000.0 in Q2 2024 and a low of $2000.0 during Q4 2024
- For the 5-year period, Benitec Biopharma's Receivables averaged around $37058.8, with its median value being $10000.0 (2021).
- As far as peak fluctuations go, Benitec Biopharma's Receivables skyrocketed by 173333.33% in 2023, and later plummeted by 9622.64% in 2024.
- Benitec Biopharma's Receivables (Quarter) stood at $5000.0 in 2021, then soared by 1260.0% to $68000.0 in 2022, then fell by 22.06% to $53000.0 in 2023, then plummeted by 96.23% to $2000.0 in 2024, then skyrocketed by 50.0% to $3000.0 in 2025.
- Its Receivables stands at $3000.0 for Q1 2025, versus $2000.0 for Q4 2024 and $4000.0 for Q3 2024.